Key Takeaways
- • HSG, formerly known as Sequoia China, has acquired an approximately 80% stake in PeierTech, a Chinese manufacturer of medical-grade nitinol materials and precision components, according to a PeierTech statement issued Thursday.
- • Existing management retains the remaining equity and will continue to run day-to-day operations, with CEO Amy Shen remaining in place.
- • HSG plans to introduce a market-based equity incentive programme for key management to support growth and international expansion.
- • PeierTech, founded in 2002 and based in Jiangyin, Jiangsu, supplies medical device makers in more than 20 countries across cardiovascular, neurovascular, gastrointestinal and orthopaedic applications.
- • HSG manages more than $61 billion in assets for institutional investors as of June 30, 2026, and has backed more than 1,800 companies since its 2005 founding.
Summary
HSG, formerly known as Sequoia China, has acquired an approximately 80% stake in PeierTech, a Chinese manufacturer of medical-grade nitinol materials and precision components. The transaction gives HSG a controlling interest in the company, PeierTech said in a statement on Thursday. The firm is expanding its healthcare portfolio with the deal.
PeierTech's existing management team will retain the remaining equity and continue to oversee day-to-day operations. HSG also plans to introduce a market-based equity incentive programme for key management members to support the company's growth and international expansion.
Founded in 2002 and headquartered in Jiangyin, Jiangsu province, PeierTech supplies medical device manufacturers in more than 20 countries. Its products include nitinol wire and tubing, precision processing and device assembly for cardiovascular, neurovascular, gastrointestinal and orthopaedic applications. Its manufacturing capabilities span laser cutting and welding, heat treatment, surface finishing, braiding and precision assembly.
HSG partner Steve Jia said PeierTech has established a leading global position in a highly specialised segment of medical device manufacturing, built on deep technical expertise and longstanding customer relationships. He cited opportunities to strengthen that position through international expansion, operational improvements and market consolidation. PeierTech chief executive Amy Shen said the investment would provide financial support, international experience and an industry network for the company's next phase of growth.
HSG manages more than $61 billion in assets for institutional investors as of June 30, 2026, according to the firm. Since its founding in 2005, it has backed more than 1,800 companies across technology, healthcare and consumer sectors.
PeierTech's existing management team will retain the remaining equity and continue to oversee day-to-day operations. HSG also plans to introduce a market-based equity incentive programme for key management members to support the company's growth and international expansion.
Founded in 2002 and headquartered in Jiangyin, Jiangsu province, PeierTech supplies medical device manufacturers in more than 20 countries. Its products include nitinol wire and tubing, precision processing and device assembly for cardiovascular, neurovascular, gastrointestinal and orthopaedic applications. Its manufacturing capabilities span laser cutting and welding, heat treatment, surface finishing, braiding and precision assembly.
HSG partner Steve Jia said PeierTech has established a leading global position in a highly specialised segment of medical device manufacturing, built on deep technical expertise and longstanding customer relationships. He cited opportunities to strengthen that position through international expansion, operational improvements and market consolidation. PeierTech chief executive Amy Shen said the investment would provide financial support, international experience and an industry network for the company's next phase of growth.
HSG manages more than $61 billion in assets for institutional investors as of June 30, 2026, according to the firm. Since its founding in 2005, it has backed more than 1,800 companies across technology, healthcare and consumer sectors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.